二甲基亚砜通过促进上皮干细胞DNA双链断裂修复预防放射性口腔黏膜炎
本研究在C57BL/6J小鼠头颈部单次大剂量及分次照射模型中评估二甲基亚砜(DMSO)对急性放射性口腔黏膜炎的疗效。结果显示,DMSO预处理可保护口腔黏膜免受严重急性放射损伤、减轻照射所致体重下降,且对荷瘤小鼠肿瘤重量无显著影响;DMSO疗效优于重组人角质细胞生长因子和氨磷汀。机制上,DMSO通过促进p63阳性上皮干细胞DNA双链断裂修复、防止增殖性舌上皮干/祖细胞丢失而发挥作用。
要点
- DMSO预处理可保护小鼠口腔黏膜免受严重急性放射损伤并减轻照射所致体重下降。
- DMSO疗效优于重组人角质细胞生长因子和氨磷汀。
- DMSO通过促进p63阳性上皮干细胞DNA双链断裂修复防止增殖性舌上皮干/祖细胞丢失。
核心结论
- DMSO通过促进DNA双链断裂修复防止照射后增殖性舌上皮干/祖细胞丢失,从而预防放射性口腔黏膜炎且不保护肿瘤。
- 作者认为,鉴于DMSO高效低毒,其可能成为预防放射性口腔黏膜炎的潜在治疗选择。
研究设计与样本
- 在C57BL/6J小鼠中通过头颈部单次大剂量及分次照射诱导口腔黏膜炎,采用腹腔注射给予DMSO,并通过宏观和组织病理学检查评估效果。
- 通过p63和Ki-67免疫组化染色分析上皮干/祖细胞,通过γ-H2AX免疫荧光检测显示DNA双链断裂。
- 使用CAL-27细胞建立肿瘤异种移植模型。
主要发现
- DMSO预处理保护口腔黏膜免受严重急性放射损伤,减轻放射所致体重下降,且对受照或未受照异种移植小鼠的肿瘤重量无显著影响。
- DMSO疗效优于重组人角质细胞生长因子和氨磷汀。
- DMSO处理防止照射后增殖性舌上皮干/祖细胞丢失。
- 照射后6小时p63阳性上皮干细胞中γ-H2AX foci平均水平显著降低,但照射后2小时未显著降低,表明DMSO促进DNA双链断裂修复而非抑制照射的间接作用。
临床怎么用
- 原文结论指出,鉴于DMSO高效低毒,其可能成为预防放射性口腔黏膜炎的潜在治疗选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Oral mucositis is one of the most prevalent side effects in patients undergoing radiation therapy for head and neck cancers. Current therapeutic agents such as palifermin recombinant human keratinocyte growth factor and amifostine do not efficiently or fully prevent mucositis. Dimethyl sulfoxide (DMSO), a free-radical scavenger, has shown therapeutic benefits in many preclinical and clinical studies. This study aimed to investigate the efficacy of DMSO in a clinically relevant mouse model of acute, radiation-induced oral mucositis. METHODS AND MATERIALS: Oral mucositis was induced by a high single and fractioned irradiation of the head and neck area in C57BL/6J mice, and the effects of DMSO (by intraperitoneal injection) were assessed by macroscopic and histopathological examination. Epithelial stem and progenitor cells were analyzed by immunohistochemical staining of p63 and Ki-67, and DNA double-strand breaks (DSBs) were visualized by immunofluorescence detection of γ-H2AX. Tumor xenograft was obtained using CAL-27 cells. RESULTS: Pretreatment with DMSO protected the oral mucosa from severe acute radiation injury, reduced the extent of radiation-induced weight loss, and had no significant effects on tumor weight in irradiated or nonirradiated xenograft mice. Furthermore, the efficacy of DMSO was superior to that of recombinant human keratinocyte growth factor and amifostine. DMSO treatment prevented the loss of proliferative lingual epithelial stem and progenitor cells upon irradiation. More interestingly, the average levels of γ-H2AX foci were significantly decreased in p63-positive epithelial stem cells at 6 hours, but not at 2 hours, after irradiation, indicating that DMSO facilitated DNA DSB repair rather than suppressing the indirect action of irradiation. CONCLUSIONS: DMSO prevents the loss of proliferative lingual epithelial stem and progenitor cells upon irradiation by facilitating DNA DSB repair, thereby protecting against radiation-induced mucositis without tumor protection. Given its high efficacy and low toxicity, DMSO could be a potential treatment option to prevent radiation-induced oral mucositis.
引用
- Yang C, Tang H, Wang L, et al. Dimethyl Sulfoxide Prevents Radiation-Induced Oral Mucositis Through Facilitating DNA Double-Strand Break Repair in Epithelial Stem Cells. Int J Radiat Oncol Biol Phys. 2018. PMID: 30092334. doi:10.1016/j.ijrobp.2018.07.2010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。